Overhaul in pharma manufacturing: India imposes stringent quality controls.

Source: Business Line

Concerns raised by health authorities and non-compliance with international standards have prompted this push, with large companies given a six-month deadline and smaller ones a 12-month timeframe to comply.

India has tightened rules to ensure mandatory compliance with good manufacturing practices – which looks at bringing in quality control on materials, machines, processes, personnel, and facilities – by pharma companies. 

All pharma companies must follow the revised good manufacturing practices and comply with the rules over 6-12 months. 

While for small companies or MSMEs, with a turnover of lower than Rs 250 crore, compliance and certification processes are to be completed over a 12-month-period; larger ones or those with a turnover greater than Rs 250 crore need to put in place these compliances over the next six months. 

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *